tiprankstipranks
Trending News
More News >
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
India Market
Advertisement

Suven Pharmaceuticals Ltd. (SUVENPHAR) Income Statement

Compare
2 Followers

Suven Pharmaceuticals Ltd. Income Statement

Last quarter (Q3 2025), Suven Pharmaceuticals Ltd.'s total revenue was ₹3.07B, an increase of 39.73% from the same quarter last year. In Q3, Suven Pharmaceuticals Ltd.'s net income was ₹828.80M. See Suven Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 11.98B₹ 10.51B₹ 13.40B₹ 12.90B₹ 9.80B
Gross Profit
₹ 8.92B₹ 6.01B₹ 7.55B₹ 7.35B₹ 5.60B
Operating Expenses
₹ 5.95B₹ 1.40B₹ 2.36B₹ 1.92B₹ 1.48B
Depreciation and Amortization
₹ 774.90M₹ 545.96M₹ 477.32M₹ 390.97M₹ 316.36M
EBITDA
₹ 4.34B₹ 4.68B₹ 6.20B₹ 6.74B₹ 4.57B
Operating Income
₹ 2.98B₹ 4.61B₹ 5.19B₹ 5.42B₹ 4.10B
Other Income/Expenses
₹ 462.10M₹ -550.93M₹ -706.22M₹ 342.03M₹ -153.90M
Pretax Income
₹ 3.44B₹ 4.06B₹ 5.60B₹ 6.68B₹ 4.68B
Net Income
₹ 2.65B₹ 3.00B₹ 4.11B₹ 4.54B₹ 3.62B
Per Share Metrics
Basic EPS
₹ 10.52₹ 11.80₹ 16.16₹ 17.83₹ 14.23
Diluted EPS
₹ 10.45₹ 11.80₹ 16.16₹ 17.83₹ 14.23
Weighted Average Shares Outstanding
251.68M 254.48M 254.56M 254.56M 254.56M
Weighted Average Shares Outstanding (Diluted)
253.37M 254.56M 254.56M 254.56M 254.56M
Currency in INR

Suven Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis